Bayer's Supply Network-Centric Approach to Digitalization
Chris Grail, Bayer Pharmaceutical's engineering and maintenance excellence lead, shared insights on his company’s digitalization efforts ahead of the 2024 ISPE Pharma 4.0™ and Annex 1 Conference in December. Grail discussed how Bayer is orchestrating and prioritizing its digitalization strategy, what specific technologies they believe are the most important for the pursuit of Pharma 4.0™, how they measure ROI, and more.
Grail’s Bayer colleague, Marco Cesana, discussed the topic at the event.
Learn more about ISPE conferences.
About Bioprocess Online
Bioprocess Online is part of the Life Science Connect media group. The publication provides technical information, industry knowledge, and content for the biotherapeutic community. Audiences include bioprocess engineers, scientists, bioprocessing managers, biotechnology producers, consultants, QA/QC, project managers, directors, purchasers, marketers, and those involved in biopharm supply chain or facilities management.